287 related articles for article (PubMed ID: 15548147)
1. Reproductive factors and extreme levels of maternal serum alpha-fetoprotein: a population-based study.
Lei U; Wohlfahrt J; Christens P; Westergaard T; Lambe M; Nørgaard-Pedersen B; Melbye M
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1147-51. PubMed ID: 15548147
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum alpha-fetoprotein level during pregnancy and isolated cryptorchidism in male offspring.
Boyd HA; Myrup C; Wohlfahrt J; Westergaard T; Nørgaard-Pedersen B; Melbye M
Am J Epidemiol; 2006 Sep; 164(5):478-86. PubMed ID: 16790515
[TBL] [Abstract][Full Text] [Related]
3. High maternal serum alpha-fetoprotein and low birthweight. A study concerning possible correlation between maternal weight, smoking, and serum alpha-fetoprotein and subsequent birthweight and gestational age.
Secher NJ; Eriksen PS; Hansen PK; Lenstrup C; Thisted J
Am J Perinatol; 1985 Apr; 2(2):78-81. PubMed ID: 2420339
[TBL] [Abstract][Full Text] [Related]
4. Maternal and biochemical predictors of spontaneous preterm birth among nulliparous women: a systematic analysis in relation to the degree of prematurity.
Smith GC; Shah I; White IR; Pell JP; Crossley JA; Dobbie R
Int J Epidemiol; 2006 Oct; 35(5):1169-77. PubMed ID: 16882673
[TBL] [Abstract][Full Text] [Related]
5. Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome.
Smith GC; Wood AM; Pell JP; White IR; Crossley JA; Dobbie R
N Engl J Med; 2004 Sep; 351(10):978-86. PubMed ID: 15342806
[TBL] [Abstract][Full Text] [Related]
6. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
7. Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Richardson BE; Peck JD; Wormuth JK
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1349-55. PubMed ID: 11142421
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
9. Maternal levels of alpha-fetoprotein in African women.
Rogo KO; Onyango GK; Ojwang PJ; Sekkade-Kigondu C
East Afr Med J; 1991 Aug; 68(8):601-5. PubMed ID: 1722453
[TBL] [Abstract][Full Text] [Related]
10. Mid-pregnancy maternal plasma levels of interleukin 2, 6, and 12, tumor necrosis factor-alpha, interferon-gamma, and granulocyte-macrophage colony-stimulating factor and spontaneous preterm delivery.
Curry AE; Vogel I; Drews C; Schendel D; Skogstrand K; Flanders WD; Hougaard D; Olsen J; Thorsen P
Acta Obstet Gynecol Scand; 2007; 86(9):1103-10. PubMed ID: 17712652
[TBL] [Abstract][Full Text] [Related]
11. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
[TBL] [Abstract][Full Text] [Related]
12. Maternal and fetal serum transformed alpha-fetoprotein levels in normal pregnancy.
González-Bugatto F; Foncubierta E; Bailén Mde L; Illanes S; Hervías-Vivancos B; Bartha JL
J Obstet Gynaecol Res; 2009 Apr; 35(2):271-6. PubMed ID: 19453690
[TBL] [Abstract][Full Text] [Related]
13. Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Bredaki FE; Sciorio C; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jul; 46(1):34-41. PubMed ID: 25652769
[TBL] [Abstract][Full Text] [Related]
14. First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels.
Cowans NJ; Spencer K
Prenat Diagn; 2005 Aug; 25(8):693-9. PubMed ID: 16050001
[TBL] [Abstract][Full Text] [Related]
15. Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers.
Dugoff L; Cuckle HS; Hobbins JC; Malone FD; Belfort MA; Nyberg DA; Comstock CH; Saade GR; Eddleman KA; Dar P; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Am J Obstet Gynecol; 2008 Sep; 199(3):290.e1-6. PubMed ID: 18771987
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and alpha-fetoprotein levels in maternal and umbilical cord blood samples in relation to birth weight.
Nagata C; Iwasa S; Shiraki M; Shimizu H
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1469-72. PubMed ID: 16896034
[TBL] [Abstract][Full Text] [Related]
17. [Significant effects on alpha-fetoprotein (AFP) concentration in maternal serum in pregnancy].
Greiff R; Schlosser H; Amse T
Zentralbl Gynakol; 1991; 113(5):253-7. PubMed ID: 1711749
[TBL] [Abstract][Full Text] [Related]
18. Women who gave birth to girls with Turner syndrome: maternal and neonatal characteristics.
Hagman A; Wennerholm UB; Källén K; Barrenäs ML; Landin-Wilhelmsen K; Hanson C; Bryman I
Hum Reprod; 2010 Jun; 25(6):1553-60. PubMed ID: 20237051
[TBL] [Abstract][Full Text] [Related]
19. Very low alpha-fetoprotein in Down syndrome maternal serum screening.
Muller F; Dreux S; Sault C; Galland A; Puissant H; Couplet G; Lemay C; Larcher ME; Renom G;
Prenat Diagn; 2003 Jul; 23(7):584-7. PubMed ID: 12868089
[TBL] [Abstract][Full Text] [Related]
20. Maternal cortisol and offspring birthweight: results from a large prospective cohort study.
Goedhart G; Vrijkotte TG; Roseboom TJ; van der Wal MF; Cuijpers P; Bonsel GJ
Psychoneuroendocrinology; 2010 Jun; 35(5):644-52. PubMed ID: 19889503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
